| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| elacridar-adc-analys..> | 2026-04-29 03:42 | 41K | ||
| elacridar-lilly-anal..> | 2026-04-29 03:42 | 40K | ||
| GSK_Elacridar_Combin..> | 2026-04-29 03:42 | 40K | ||
| oncobayes-lilly-pitc..> | 2026-04-29 03:42 | 21K | ||
| elacridar-lilly-pitc..> | 2026-04-29 03:42 | 17K | ||
| gsk-elacridar-analys..> | 2026-04-29 03:42 | 50K | ||
| AbbVie_Elacridar_Com..> | 2026-04-29 04:04 | 50K | ||
| Roche_Elacridar_Comb..> | 2026-04-29 05:36 | 53K | ||
| AstraZeneca_Elacrida..> | 2026-04-29 05:50 | 61K | ||
| soterios.html | 2026-05-01 04:47 | 63K | ||
| oncobayes_gsk_pitch...> | 2026-05-05 03:26 | 57K | ||
| oncobayes_lilly_pitc..> | 2026-05-05 03:46 | 58K | ||
| oncobayes_bms_pitch...> | 2026-05-05 04:15 | 59K | ||
| oncobayes_ob001_evid..> | 2026-05-05 06:02 | 34K | ||